Prostate Cancer Therapy Too Good to Be True Explodes Health Cost

Imagine a prostate cancer therapy that has almost no side effects. Hospitals say it exists and they’re vying to be among the first to offer it. Too bad the treatment may not work as well as advertised and could boost America’s already spiraling health-care costs.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.